您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Cyclobenzaprine-d3(hydrochloride)(CRM)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cyclobenzaprine-d3(hydrochloride)(CRM)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Cyclobenzaprine-d3(hydrochloride)(CRM)图片
包装:1mg
规格:98%
市场价:1721元
分子量:314.9

产品介绍
A Certified Reference Material
货号:ajcx24578
CAS:1184983-42-3
分子式:C20H18D3N•HCl
分子量:314.9
溶解度:
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Cyclobenzaprine-d3(hydrochloride) (CRM) contains three deuterium atoms at the terminal methyl group. It is intended for use as an internal standard for the quantification of cyclobenzaprine by GC- or LC-mass spectrometry. Cyclobenzaprine is a skeletal muscle relaxant that also has sedative properties.1,2,3It has been shown to antagonize muscarinic receptors (Kis = 25, 60, and 6 nM for M1, M2, and M3, respectively), serotonin 5-HT2receptors (Kis = 56 and 330 nM for 5-HT2Cand 5-HT2B, respectively), and histamine H1receptor (IC50= 20 nM).4,5,6


1.Trivedi, R.K., and Patel, M.C.Development of a stability-indicating RP-UPLC method for rapid determination of metaxalone and its degradation products in solid oral dosage formSci.Pharm.80(2)353-366(2012) 2.Chou, R., Peterson, K., and Helfand, M.Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: A systematic reviewJ. Pain Symptom Manage.28(2)140-175(2004) 3.See, S., and Ginzburg, R.Choosing a skeletal muscle relaxantAmerican Family Physician78(3)365-370(2008) 4.Gregori-PuigjanÉ, E., Setola, V., Hert, J., et al.Identifying mechanism-of-action targets for drugs and probesProc. Natl. Acad. Sci. USA109(28)11178-11183(2012) 5.Honda, M., Nishida, T., and Ono, H.Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT2 receptorsEuropean Journal of Pharmacology458(1-2)91-99(2003) 6.Lounkine, E., Keiser, M.J., Whitebread, S., et al.Large scale prediction and testing of drug activity on side-effect targetsNature486(7403)361-367(2012)